|
|
|
|
|
|
|
|
open access
To our knowledge this Is only the third report in the literature demonstrating that Sunitinib monotherapy can provoke a response in chemotherapy refractory clear cell ovarian cancer.
|
|
|
|
|
|
|
|
To our knowledge this Is only the third report in the literature demonstrating that Sunitinib monotherapy can provoke a response in chemotherapy refractory clear cell ovarian cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.